CJC-1295 Therapy
Support Natural Growth Hormone Signaling
CJC-1295 therapy at AlphaCare is a medically supervised peptide program designed to stimulate the body’s natural growth hormone release. Our approach prioritizes safety, conservative dosing, and ongoing monitoring within a structured care plan.
What Is CJC-1295?
CJC-1295 is a synthetic peptide that acts on growth hormone–releasing hormone (GHRH) receptors, encouraging the body to release its own growth hormone in a physiologic manner. Unlike direct growth hormone injections, CJC-1295 works by supporting natural hormone signaling rather than replacing hormones.
Our structured peptide program includes:
- Initial medical evaluation
- Review of symptoms and medical history
- Personalized dosing protocol
- Injection education and training
- Scheduled follow-up monitoring
Treatment is goal-directed and reassessed regularly.
CJC-1295 may be discussed if you experience:
- Poor recovery after exercise
- Disrupted or non-restorative sleep
- Difficulty maintaining lean muscle mass
- Signs of age-related decline in growth hormone signaling
Some patients may notice improvements in sleep quality within a few weeks. Changes in body composition or recovery often require several months of consistent therapy. Results vary by individual and are not guaranteed.
CJC-1295 is NOT a bodybuilding or performance-enhancing drug, a shortcut for poor sleep or nutrition, a substitute for exercise, or a permanent hormone replacement.
How Is CJC-1295 Taken?
- Typically injected once daily or several times weekly, depending on protocol
- Often administered in the evening to align with natural growth hormone release
- Treatment courses typically last several weeks to months
Possible Side Effects
CJC-1295 is generally well tolerated. Possible side effects may include injection site irritation, headache, and mild flushing or nausea. Significant side effects are uncommon when used appropriately.
Why Choose AlphaCare for CJC-1295 Therapy
CJC-1295 is not FDA-approved, and long-term outcome data are limited. While research shows it can increase growth hormone and IGF-1 levels, most studies are short-term. AlphaCare uses a conservative, evidence-informed approach—offering treatment only after medical evaluation, with goal-directed, time-limited protocols and close monitoring to prioritize safety.
Safety, Monitoring, and Medical Oversight
Safe when prescribed by a physician. We carefully monitor dosage to ensure physiological balance and prevent joint swelling or insulin resistance.
Frequently Asked Questions.
No. CJC-1295 is not FDA-approved.
No. CJC-1295 stimulates your body’s own growth hormone release.
Duration depends on response and goals; therapy is reassessed regularly.
Competitive athletes should discuss eligibility with their provider.
When to Contact AlphaCare
Contact AlphaCare if you experience worsening symptoms, unexpected side effects, or no improvement within the expected treatment window. Seek emergency care for severe or concerning symptoms.